Rock Creek Group, LP Bristol Myers Squibb CO Transaction History

Rock Creek Group, LP

$1 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $36,297 - $40,585	-627 Reduced 19.22%	2,636 $152,000
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $9,046 - $10,045	142 Added 4.55%	3,263 $208,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $4,336 - $4,918	-66 Reduced 2.07%	3,121 $216,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $53,140 - $62,925	-776 Reduced 19.58%	3,187 $229,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $225 - $133,471	-1,737 Reduced 30.47%	3,963 $282,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $96,947 - $106,773	1,335 Added 30.58%	5,700 $439,000
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $80,907 - $97,015	1,316 Added 43.16%	4,365 $319,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $6,542 - $7,627	-122 Reduced 3.85%	3,049 $190,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $112,186 - $131,411	-1,896 Reduced 37.42%	3,171 $188,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $60,919 - $66,341	984 Added 24.1%	5,067 $339,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $353,429 - $397,503	-5,956 Reduced 59.33%	4,083 $258,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $139,326 - $157,882	-2,413 Reduced 19.38%	10,039 $623,000
Q3 2020 Oct 30, 2020	SELL	$57.43 - $63.64 $1.2 Million - $1.33 Million	-20,840 Reduced 62.6%	12,452 $751,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $263,739 - $308,336	-4,811 Reduced 12.63%	33,292 $1.96 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $911,528 - $1.32 Million	19,645 Added 106.43%	38,103 $2.12 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $44,239 - $57,706	-899 Reduced 4.64%	18,458 $1.18 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $7,099 - $8,417	166 Added 0.86%	19,357 $982,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $299,444 - $331,120	6,711 Added 53.77%	19,191 $870,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $563,097 - $671,424	12,480 New	12,480 $595,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.

Account